Cybin to participate in the oppenheimer 33rd annual healthcare conference

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing psychedelics to therapeutics® is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a virtual fireside chat at the oppenheimer 33rd annual healthcare conference taking place on march 13-15, 2023. mr. drysdale's fireside chat will be webcast live on tuesday, march 14, 2023 at 12:40 p.m. et.
CYBN Ratings Summary
CYBN Quant Ranking